CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated co-stimulation

被引:46
|
作者
Girvin, AM
Dal Canto, MC
Miller, SD
机构
[1] Northwestern Univ, Sch Med, Dept Immunol Microbiol, Chicago, IL 60611 USA
[2] Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA
[3] Northwestern Univ, Sch Med, Interdepartmental Immunobiol Ctr, Chicago, IL 60611 USA
[4] Northwestern Univ, Inst Neurosci, Chicago, IL 60611 USA
关键词
autoimmunity; co-stimulatory molecules; EAE/MS; immunotherapy; neuroimmunology;
D O I
10.1006/jaut.2001.0573
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD28 provides a co-stimulatory signal critical for optimal T cell activation. We and others have shown that the B7/CD28 co-stimulatory pathway is a major regulatory pathway for the control of immune responses. Experimentally induced models of autoimmunity have been shown to be prevented of reduced in intensity in mice deficient for CD28. Here, we show that EAE and accompanying neuroantigen-specific immune responses are drastically reduced in the absence of CD28. However, we go on to show that EAE can be induced in CD28-deficient mice following two immunizations. After re-immunization, CD28-deficient mice develop severe EAE with myelin-specific responses equal to those of wildtype controls, and extensive demyelination in the spinal cord. Treatment of CD28-deficient mice with anti-CD46L at the time of immunization significantly reduced DTH responses and prevented the development of EAE following two immunizations, indicating a critical 0 role for CD40/CD40L signaling in the absence of CD28. Taken together, our results indicate that CD28-mediated co-stimulation does not regulate immunological anergy, Instead, CD28 appears to adjust the threshold for activation and expansion of autoreactive cells. (C) 2002 Elsevier Science Ltd.
引用
收藏
页码:83 / 94
页数:12
相关论文
共 50 条
  • [41] Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
    Cognasse, Fabrice
    Duchez, Anne Claire
    Audoux, Estelle
    Ebermeyer, Theo
    Arthaud, Charles Antoine
    Prier, Amelie
    Eyraud, Marie Ange
    Mismetti, Patrick
    Garraud, Olivier
    Bertoletti, Laurent
    Hamzeh-Cognasse, Hind
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [42] CD40/CD40L与疾病研究进展
    覃淑娟
    柳广南
    医学综述, 2009, 15 (19) : 2905 - 2908
  • [43] Blocking CD40–CD40L interactions in Sjögren syndrome
    Jessica McHugh
    Nature Reviews Rheumatology, 2019, 15 : 252 - 252
  • [44] Involvement of the CD40/CD40L system in systolic heart failure
    Natal, C.
    Fortuno, M. A.
    Lopez, N.
    Lopez, B.
    Gonzalez, A.
    Beloqui, O.
    Diez, J.
    Varo, N.
    EUROPEAN HEART JOURNAL, 2006, 27 : 489 - 489
  • [45] Expression of CD40 and CD40L in inflammatory bowel disease.
    Liu, Z
    Colpaert, S
    Van den Broeck, C
    D'Haens, G
    Ceuppens, J
    Geboes, K
    Rutgeerts, P
    GASTROENTEROLOGY, 1998, 114 (04) : A1024 - A1024
  • [46] CD40-targeting KGYY15 peptides do not efficiently block the CD40–CD40L interaction
    Damir Bojadzic
    Peter Buchwald
    Diabetologia, 2019, 62 : 2158 - 2160
  • [47] Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway
    Ha, JW
    Bingaman, AW
    Durham, MM
    Pearson, TC
    Larsen, CP
    TRANSPLANT IMMUNOLOGY, 2001, 9 (01) : 13 - 17
  • [48] Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling
    Wieckowski, Sebastien
    Trouche, Nathalie
    Chaloin, Olivier
    Guichard, Gilles
    Fournel, Sylvie
    Hoebeke, Johan
    BIOCHEMISTRY, 2007, 46 (11) : 3482 - 3493
  • [49] Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapy
    Solanki, Kundan
    Kumar, Ashutosh
    Khan, Mohd Shahnawaz
    Karthikeyan, Subramani
    Atre, Rajat
    Zhang, Kam Y. J.
    Bezsonov, Evgeny
    Obukhov, Alexander G.
    Baig, Mirza S.
    CURRENT RESEARCH IN STRUCTURAL BIOLOGY, 2023, 6
  • [50] PD1 functions by inhibiting CD28-mediated co-stimulation
    O'Donnell, Jake S.
    Smyth, Mark J.
    Teng, Michele W. L.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2017, 6